A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study.
about
Nausea: a review of pathophysiology and therapeuticsChemotherapy-induced nausea and vomiting: optimizing prevention and managementOlanzapine: an antiemetic option for chemotherapy-induced nausea and vomitingUpdate and new trends in antiemetic therapy: the continuing need for novel therapies.Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.Emerging drugs for chemotherapy-induced emesis.The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South IndiaClinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting.Olanzapine for the Prevention of Chemotherapy-Induced Nausea and VomitingA meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomitingOlanzapine for nausea and vomiting.Olanzapine: palliative medicine update.Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: a retrospective, multi-center review.Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature.Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.Central Aspects of Nausea and Vomiting in GI Disorders.Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis.A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy.QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist.Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis.Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial.Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity.EAPC Abstracts
P2860
Q26771877-5350ABA4-E691-4A45-922E-2789C73B4C9AQ26852601-39A4992E-AFC3-42ED-9B39-ABF595749B97Q33886138-BA12E0C6-0674-41E9-B3CA-3369606EC602Q34143667-80CCAA99-1C28-4FBE-90AF-5B872BD1F57CQ34327488-A118740E-ACE3-4E21-A791-942D651EFF87Q36407422-14E8BAE4-B5CB-4303-9D39-A477742A1298Q36564514-02EBBBC7-5FA7-4702-910A-AC9D7EF780F8Q37387345-C408D317-312D-419E-A266-97C0196C9154Q37691654-BFF69596-9497-4F02-8312-90F3EF472B0FQ37738165-19D42519-EB11-404B-9149-F80808ADA2D4Q37761263-5679761F-9DD4-4FD6-ABF2-276EB01A7A8EQ38001959-943CA089-79B5-4B19-88C8-F95838F3D7C4Q38187578-051976F7-7352-46B5-8D9B-78CB610E79DEQ38261290-FB378413-F714-48EB-BF43-D3458AC1D07BQ38533535-BBC52FB4-FA70-4DB0-9F21-696D4FB53C35Q38623597-1CE3B053-4BCB-490F-A9F3-FAE97AA3EF5BQ38696953-FFE7C664-F123-4EAE-B3DF-92DF23557FDAQ38739169-6AC6F8BC-80D8-440C-AB27-1DA965CB263BQ38786773-B976806B-0199-4411-9A46-44BD32BC2559Q38979261-F0248ACE-0BFA-40DD-AA49-16B451195350Q39005867-AD6EDF71-D1A0-4DA8-9655-5E1EBB5E2DBFQ47741649-AD0B4CCF-EDDC-4893-92DD-03772166FD8FQ48016196-B02BFF6D-B001-4ABF-9AE9-27A55F3E855FQ48251989-8684AA88-E920-4F48-9025-2AE2DC1E24F0Q50441498-0ECCFDCF-8DF2-490A-B4EF-630D13DC7077Q50469957-ECA0D5B2-1BE2-42A5-B8C8-33E96DB7EECBQ57582678-2CE322D4-CAEF-4D99-ABCA-C238D43F16E5
P2860
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A phase I trial of olanzapine ...... Hoosier Oncology Group study.
@en
A phase I trial of olanzapine
@nl
type
label
A phase I trial of olanzapine ...... Hoosier Oncology Group study.
@en
A phase I trial of olanzapine
@nl
prefLabel
A phase I trial of olanzapine ...... Hoosier Oncology Group study.
@en
A phase I trial of olanzapine
@nl
P2093
P2860
P356
P1433
P1476
A phase I trial of olanzapine ...... Hoosier Oncology Group study.
@en
P2093
Cindy Nagy
Jake Vinson
Kenneth L Kirsh
Patrick Loehrer
Rudolph M Navari
Sin-Ho Jung
Steven D Passik
P2860
P304
P356
10.1081/CNV-200029066
P577
2004-01-01T00:00:00Z